Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mark Adams, Teri Willey, Zunyan Dai, Daniel Sharer, Patricia Hall, More

Premium

Good Start Genetics has appointed Mark Adams to Chief Information Officer. Adams joins Good Start from Bridgewater Associates and was previously a principal with Booz Allen Hamilton, where he developed a biomedical informatics consulting practice. He has also been vice president of bioinformatics at Variagenics, and held positions at Incyte. He holds a BA from Oberlin College and a PhD from Baylor College of Medicine.


Cold Spring Harbor Laboratory has appointed Teri Willey to VP of Business Development & Technology Transfer, where she will direct the laboratory's commercialization and technology transfer activities including patenting, licensing, company start-ups, and corporate partnerships and collaborations. She is taking over for John Maroney, who will continue in his role as general counsel.

Willey joins CSHL from Mount Sinai Medical Center, and was also Founding Executive Director of Cambridge Enterprise. She has also served as an advisor to Congress and is a past President of the Association of University Technology Managers.


Emory Genetics Laboratory has hired five new directors that will join full-time within the next month. Zunyan Dai has joined EGL from Quest and will serve as Director, Cytogenetics Laboratory. Daniel Sharer from the University of Alabama at Birmingham and Patricia Hall from the Mayo Clinic will both serve as Director, Biochemical Genetics Laboratory. John Alexander from the University of Alabama at Birmingham; Yuan Xue from the University of California, Los Angeles; and Alice Tanner, a board certified genetic counselor at Emory, will all serve as Director, Molecular Genetics Laboratory.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.